Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Regional Trends in Mortality from Alcohol-Induced Causes in the United States, 2000-2017.

Cholankeril G, Dennis BB, Kim D, Ahmed A.

J Gen Intern Med. 2019 Dec 2. doi: 10.1007/s11606-019-05442-4. [Epub ahead of print] No abstract available.

PMID:
31792862
2.

Meeting Report: The Dallas consensus conference on liver transplantation for alcohol related hepatitis.

Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G.

Liver Transpl. 2019 Nov 19. doi: 10.1002/lt.25681. [Epub ahead of print]

PMID:
31743578
3.

Post-transplant Outcome of Lean Compared to Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox.

Satapathy SK, Jiang Y, Agbim U, Wu C, Bernstein DE, Teperman LW, Kedia SK, Aithal GP, Bhamidimarri KR, Duseja A, Maiwall R, Maliakkal B, Jalal P, Patel K, Puri P, Ravinuthala R, Wong VW, Abdelmalek MF, Ahmed A, Thuluvath PJ, Singal AK; Global NAFLD Consortium.

Liver Transpl. 2019 Oct 30. doi: 10.1002/lt.25672. [Epub ahead of print]

PMID:
31665561
4.

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.

Kim D, Kim W, Joo SK, Han J, Kim JH, Harrison SA, Younossi ZM, Ahmed A.

J Gastroenterol. 2019 Sep 18. doi: 10.1007/s00535-019-01628-z. [Epub ahead of print]

PMID:
31535207
5.

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.

Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A.

J Palliat Med. 2019 Aug 9. doi: 10.1089/jpm.2019.0100. [Epub ahead of print]

PMID:
31397615
6.

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A.

Dig Dis Sci. 2019 Aug 1. doi: 10.1007/s10620-019-05759-4. [Epub ahead of print]

PMID:
31372912
7.

Treatment of inoperable hepatocellular carcinoma with immunotherapy.

Tighe SP, Iqbal U, Fernandes CT, Ahmed A.

BMJ Case Rep. 2019 Jul 27;12(7). pii: e229744. doi: 10.1136/bcr-2019-229744.

PMID:
31352386
8.

Depression is associated with non-alcoholic fatty liver disease among adults in the United States.

Kim D, Yoo ER, Li AA, Tighe SP, Cholankeril G, Harrison SA, Ahmed A.

Aliment Pharmacol Ther. 2019 Sep;50(5):590-598. doi: 10.1111/apt.15395. Epub 2019 Jul 22.

PMID:
31328300
9.

Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.

Samji NS, Verma R, Keri KC, Singal AK, Ahmed A, Rinella M, Bernstein D, Abdelmalek MF, Satapathy SK.

Dig Dis Sci. 2019 Dec;64(12):3413-3430. doi: 10.1007/s10620-019-05716-1. Epub 2019 Jul 16. Review.

PMID:
31312990
10.

Potential Mechanisms Influencing the Inverse Relationship Between Cannabis and Nonalcoholic Fatty Liver Disease: A Commentary.

Dibba P, Li AA, Cholankeril G, Ali Khan M, Kim D, Ahmed A.

Nutr Metab Insights. 2019 May 13;12:1178638819847480. doi: 10.1177/1178638819847480. eCollection 2019.

11.

Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution.

Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A.

J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14778. [Epub ahead of print]

PMID:
31272131
12.

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2019 Oct;157(4):1055-1066.e11. doi: 10.1053/j.gastro.2019.06.026. Epub 2019 Jun 25.

PMID:
31251928
13.

Impact of sarcopenia on the progression of nonalcoholic fatty liver disease: a frequently forgotten association.

Li AA, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Jun;8(3):260-261. doi: 10.21037/hbsn.2018.12.10. No abstract available.

14.

Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017.

Kim D, Cholankeril G, Kim SH, Abbasi F, Knowles JW, Ahmed A.

Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30649-4. doi: 10.1016/j.cgh.2019.06.011. [Epub ahead of print]

PMID:
31220638
15.

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Li AA, Ahmed A, Kim D.

Gut Liver. 2019 Jun 17. doi: 10.5009/gnl19069. [Epub ahead of print]

16.

Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.

17.

Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.

Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A.

Ann Hepatol. 2019 Sep - Oct;18(5):679-684. doi: 10.1016/j.aohep.2019.04.014. Epub 2019 May 21.

18.

Economic burden and healthcare utilization in nonalcoholic fatty liver disease.

Yoo ER, Ahmed A, Kim D.

Hepatobiliary Surg Nutr. 2019 Apr;8(2):181-183. doi: 10.21037/hbsn.2018.12.11. No abstract available.

19.

Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.

Wijarnpreecha K, Panjawatanan P, Aby E, Ahmed A, Kim D.

Maturitas. 2019 Jun;124:48-54. doi: 10.1016/j.maturitas.2019.03.016. Epub 2019 Mar 25. Review.

PMID:
31097179
20.

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.

Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A.

Liver Int. 2019 Sep;39(9):1661-1671. doi: 10.1111/liv.14135. Epub 2019 Jun 4.

PMID:
31081997

Supplemental Content

Loading ...
Support Center